Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00075946
Status:
COMPLETED
Last Update Posted:
2024-02-01
First Post:
2004-01-12
Brief Title:
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkins Lymphoma
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| splenic marginal zone lymphoma | View |
| stage III grade 1 follicular lymphoma | View |
| stage III grade 2 follicular lymphoma | View |
| stage IV grade 1 follicular lymphoma | View |
| stage IV grade 2 follicular lymphoma | View |
| stage III small lymphocytic lymphoma | View |
| stage III marginal zone lymphoma | View |
| stage IV small lymphocytic lymphoma | View |
| stage IV marginal zone lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |